论文部分内容阅读
胃癌是世界范围内最常见的恶性肿瘤之一,其发病率一直位居前列。由于早期表现不明显,在确诊后多为晚期,转移和复发十分常见,已不再适应手术治疗[1]。为此当前化疗的应用比较多,但是对于化疗药物与剂量的选择还存在一定的差异。目前,基于许多临床试验结果,使用紫杉醇联合其他药物已被全世界广泛作为标准一线化疗方案[2]。本文具体探讨了不同剂量紫杉醇治疗晚期胃癌的效果,现报告如下。1资料与方法1.1临床资料选择2010年1月至2013年1月我科收治晚期胃癌住院患者56例,入选标准:预计生存
Gastric cancer is one of the most common malignancies in the world and its incidence has been among the highest. As the early manifestations are not obvious, mostly in the late diagnosis, metastasis and recurrence is very common, no longer adapt to surgical treatment [1]. Therefore, the current application of chemotherapy is more, but for the choice of chemotherapy drugs and dosage there are still some differences. Currently, based on the results of many clinical trials, the use of paclitaxel in combination with other drugs has been widely accepted as a standard first-line chemotherapy in the world [2]. This article specifically discusses the different doses of paclitaxel in the treatment of advanced gastric cancer, are as follows. 1 Materials and Methods 1.1 Clinical data selection January 2010 to January 2013 56 cases admitted to our hospital advanced gastric cancer patients, the inclusion criteria: the expected survival